Pelthos Therapeutics Inc. PTHS
22.19
(0.21)
(0.94%)
as of 25 Sep
- Market cap
- $85.8M
- P/E
- 0.0×
Follow PTHS
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 2,161.07% | (881.53%) | (239.55%) | (82.99%) |
+8 more TTM periods Free account |
|
| (125.04%) | (90.81%) | (65.75%) | (36.68%) | ||
ROIC |
(82.34%) | (51.99%) | (38.76%) | (31.61%) | |
Return on Tangible Assets |
(214.49%) | (122.76%) | (117.07%) | (67.05%) | |
Average Days of Receivables |
122.07 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(12.03) | (10.68) | (12.01) | (5.56) | |
Free Cash Flow |
(42.60) | (35.38) | (22.59) | (17.01) | |
Capital Expenditures |
(0.29) | (0.29) | — | — | |
Piotroski F-Score |
1.00 | 4.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(45.50%) | (29.99%) | (25.57%) | (23.46%) | |
Accounts Receivable Turnover |
0.00 | — | — | — | |
Accounts Payable Turnover |
1.71 | 0.00 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | — | — | — | |
Average Days of Payables |
230.43 | 0.00 | 0.00 | 0.00 | |
Days of Inventory on Hand |
845.35 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
3.01% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
200.61% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
21.31% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.49 | 0.53 | 0.52 | 0.72 | |
Depreciation/Fixed assets |
0.65 | 0.46 | 0.27 | 0.15 | |
Capex/Depreciation |
(0.05) | (0.07) | 0.00 | 0.00 | |
Revenue per Share |
12.23 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(11.95) | (10.59) | (12.01) | (5.56) | |
Capex per Share |
(0.08) | (0.09) | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.00 | — | — | |
Net Profit Margin |
(199.50%) | 0.00% | 0.00% | 0.00% |
Columns are period end dates